Rhythm Pharmaceuticals, Inc. - Common Stock (NQ:RYTM)

101.74 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2025 Add to My Watchlist

Price and Volume

Volume	1
Open	101.74
Bid (Size)	76.53 (300)
Ask (Size)	162.78 (200)
Prev. Close	101.74
Today's Range	101.74 - 101.74
52wk Range	45.91 - 116.00
Shares Outstanding	66,684,077
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

These stocks are moving in today's after hours session ↗

November 11, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.

Via Chartmill

Rhythm Pharmaceuticals Announces Presentation of Four Datasets at ObesityWeek® 2025

November 10, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Performance

YTD	+69.4%	+69.4%
1 Month	-7.9%	-7.9%
3 Month	+2.6%	+2.6%
6 Month	+71.9%	+71.9%
1 Year	+69.8%	+69.8%

More News

Rythm Pharmaceuticals' (RYTM) Chief Technical Officer Sells 9,748 Shares for $1.1 Million ↗

November 08, 2025

Via The Motley Fool

Rhythm Pharmaceuticals Announces FDA Extension of Review Period for IMCIVREE® (setmelanotide) for Patients with Acquired Hypothalamic Obesity

November 07, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Rhythm Pharmaceuticals's Earnings: A Preview ↗

November 03, 2025

Via Benzinga

Rhythm Pharmaceuticals Announces Public Reimbursement for IMCIVREE® (setmelanotide) in Canada in Five Provinces and Under the Federal Non-Insured Health Benefits Program

November 05, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Rhythm Pharmaceuticals (NASDAQ:RYTM) Reports Mixed Q3 2025 Results ↗

November 04, 2025

Via Chartmill

Rhythm Pharmaceuticals Reports Third Quarter 2025 Financial Results and Business Update

November 04, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Monday? ↗

October 27, 2025

Via Chartmill

Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025

October 21, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

2 Under-the-Radar Stocks That Could Soar ↗

September 21, 2025

Via The Motley Fool

Peering Into Rhythm Pharmaceuticals's Recent Short Interest ↗

September 11, 2025

Via Benzinga

Rhythm Pharmaceuticals Announces Participation in Upcoming Investor Conferences

August 27, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Rhythm Pharmaceuticals Announces FDA Acceptance of sNDA for Setmelanotide in Acquired Hypothalamic Obesity

August 20, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

12 Analysts Have This To Say About Rhythm Pharmaceuticals ↗

August 06, 2025

Via Benzinga

Rhythm (RYTM) Q2 Revenue Jumps 67% ↗

August 05, 2025

Via The Motley Fool

Rhythm Pharmaceuticals Inc (NASDAQ:RYTM) Reports Mixed Q2 2025 Earnings: Revenue Beat Overshadowed by Wider Losses ↗

August 05, 2025

Via Chartmill

Rhythm Pharmaceuticals Reports Second Quarter 2025 Financial Results and Business Update

August 05, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Rhythm Pharmaceuticals to Report Second Quarter 2025 Financial Results on Tuesday, August 5, 2025

July 22, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Should You Invest in This Under-the-Radar Weight Loss Stock? ↗

July 21, 2025

Via The Motley Fool

A Glimpse Into The Expert Outlook On Rhythm Pharmaceuticals Through 10 Analysts ↗

July 18, 2025

Via Benzinga

Rhythm Pharmaceuticals CFO Sells 42,120 Shares ↗

July 18, 2025

Via The Motley Fool

Rhythm Pharmaceuticals Presents Data on MC4R Agonists Setmelanotide and Bivamelagon at ENDO 2025

July 12, 2025

From Rhythm Pharmaceuticals, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Rhythm Pharmaceuticals, Inc. - Common Stock publicly traded?

Yes, Rhythm Pharmaceuticals, Inc. - Common Stock is publicly traded.

What exchange does Rhythm Pharmaceuticals, Inc. - Common Stock trade on?

Rhythm Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Rhythm Pharmaceuticals, Inc. - Common Stock?

The ticker symbol for Rhythm Pharmaceuticals, Inc. - Common Stock is RYTM on the Nasdaq Stock Market

What is the current price of Rhythm Pharmaceuticals, Inc. - Common Stock?

The current price of Rhythm Pharmaceuticals, Inc. - Common Stock is 101.74

When was Rhythm Pharmaceuticals, Inc. - Common Stock last traded?

The last trade of Rhythm Pharmaceuticals, Inc. - Common Stock was at 11/21/25 04:00 PM ET

What is the market capitalization of Rhythm Pharmaceuticals, Inc. - Common Stock?

The market capitalization of Rhythm Pharmaceuticals, Inc. - Common Stock is 6.78B

How many shares of Rhythm Pharmaceuticals, Inc. - Common Stock are outstanding?

Rhythm Pharmaceuticals, Inc. - Common Stock has 7B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.